Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer

被引:0
作者
Alexandra M. Adams
Timothy J. Vreeland
Timothy E. Newhook
机构
[1] Brooke Army Medical Center,Department of Surgery
[2] Uniformed Services University of Health Sciences,Department of Surgery
[3] Brooke Army Medical Center,Department of Surgical Oncology
[4] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
来源
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词
Circulating tumor DNA; ctDNA; Colorectal cancer; Tumor marker; Personalized medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1071 / 1081
页数:10
相关论文
共 37 条
[1]  
Ruibal Morell A(1992)CEA serum levels in non-neoplastic disease Int J Biol Markers 7 160-166
[2]  
Ballehaninna UK(2011)Serum CA 19–9 as a biomarker for pancreatic cancer-a comprehensive review Indian J Surg Oncol 2 88-100
[3]  
Chamberlain RS(1978)Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer N Engl J Med 299 448-451
[4]  
Wanebo HJ(2019)Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer JAMA Oncol 5 1118-1123
[5]  
Wang Y(2005)Detection and quantification of mutations in the plasma of patients with colorectal tumors Proc Natl Acad Sci 102 16368-16373
[6]  
Diehl F(2008)Circulating mutant DNA to assess tumor dynamics Nat Med 14 985-990
[7]  
Diehl F(2010)Circulating tumour cells in cancer patients: challenges and perspectives Trends Mol Med 16 398-406
[8]  
Pantel K(2020)ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper Nat Rev Clin Oncol 17 757-770
[9]  
Alix-Panabieres C(2013)Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA Nature 497 108-112
[10]  
Dasari A(2018)Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review Arch Pathol Lab Med 142 1242-1253